Background: The American Academy of Orthopaedic Surgeons (AAOS) and the American College of Chest Physicians (ACCP) have both developed evidence-based guidelines to prevent venous thromboembolism (VTE ...

The aim of this large international study carried out in 32 countries was to document the risk for venous thromboembolism (VTE) and the current use of appropriate therapy in hospitalized adult ...

Osimertinib for Patients With Non–Small-Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Multicenter, Open-Label, Phase II Trial (KCSG-LU15-09) The systematic review included 35 publications on ...

"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this journey through a disease state contains ...

For patients presenting with symptoms of venous thromboembolism, accurate diagnosis and treatment are essential. However, diagnosis and treatment alone are inadequate for hospitalized patients who are ...

Once-daily venous thromboembolism (VTE) prophylaxis with 10 mg of rivaroxaban for either 7 or 28 days after bariatric surgery was found to be effective and safe. Venous thromboembolism (VTE) is known ...

VTE prophylaxis is underutilized in medical patients in US hospitals, but the occurrence of VTE has a major clinical and economic impact. Data were analyzed from patients admitted to the hospital from ...

(HealthDay)—The 2014 recommendations for the prophylaxis and treatment of venous thromboembolism (VTE) in patients with cancer are unchanged from 2013, according to an article published online Jan. 20 ...

Venous thromboembolism (VTE) occurs as often as stroke, and recurs frequently, with around 30% of patients with VTE experiencing recurrence within 10 years Occurrence of VTE, especially pulmonary ...

Please provide your email address to receive an email when new articles are posted on . VTE prophylaxis significantly decreased incidence and mortality in patients with cancer at high risk for blood ...

After publication of potentially practice-changing clinical trials, identified through ASCO's signals approach to updating, an updated systematic review was performed for two guideline questions: ...